Literature DB >> 27310730

Assessing immune aging in HIV-infected patients.

Victor Appay1,2, Delphine Sauce1,2.   

Abstract

Many of the alterations that affect innate and adaptive immune cell compartments in HIV-infected patients are reminiscent of the process of immune aging, characteristic of old age. These alterations define the immunological age of individuals and are likely to participate to the decline of immune competence with HIV disease progression. It is therefore important to characterize these changes, which point toward the accumulation of highly differentiated immunocompetent cells, associated with overall telomere length shortening, as well as understanding their etiology, especially related to the impact of chronic immune activation. Particular attention should be given to the exhaustion of primary immune resources, including haematopoietic progenitors and naïve cells, which holds the key for effective hematopoiesis and immune response induction, respectively. The alteration of these compartments during HIV infection certainly represents the foundation of the immune parallel with aging.

Entities:  

Keywords:  HIV; aging; hematopoiesis; immunosenecence; lymphocytes; naïve cells

Mesh:

Year:  2016        PMID: 27310730      PMCID: PMC5538339          DOI: 10.1080/21505594.2016.1195536

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  107 in total

1.  The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines.

Authors:  Laila E Gamadia; Ester M M van Leeuwen; Ester B M Remmerswaal; Si-La Yong; Sugianto Surachno; Pauline M E Wertheim-van Dillen; Ineke J M Ten Berge; René A W Van Lier
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

2.  Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.

Authors:  Galit Alter; Nickolas Teigen; Benjamin T Davis; Marylyn M Addo; Todd J Suscovich; Michael T Waring; Hendrik Streeck; Mary N Johnston; Kyle D Staller; M Tauheed Zaman; Xu G Yu; Mathias Lichterfeld; Nesli Basgoz; Eric S Rosenberg; Marcus Altfeld
Journal:  Blood       Date:  2005-07-07       Impact factor: 22.113

3.  Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation.

Authors:  Gregor F Lichtfuss; Wan-Jung Cheng; Yagmur Farsakoglu; Geza Paukovics; Reena Rajasuriar; Pushparaj Velayudham; Marit Kramski; Anna C Hearps; Paul U Cameron; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

4.  Initiation of c-ART in HIV-1 infected patients is associated with a decrease of the metabolic activity of the thymus evaluated using FDG-PET/computed tomography.

Authors:  Jean-Daniel Lelièvre; Giovanna Melica; Emmanuel Itti; Christine Lacabaratz; Sandra Rozlan; Aurélie Wiedemann; Rémi Cheynier; Michel Meignan; Rodolphe Thiebaut; Yves Levy
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

5.  Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group.

Authors:  W T Shearer; K A Easley; J Goldfarb; H M Rosenblatt; H B Jenson; A Kovacs; K McIntosh
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

6.  Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function.

Authors:  Angela Malaspina; Susan Moir; Shyamasundaran Kottilil; Claire W Hallahan; Linda A Ehler; Shuying Liu; Marie A Planta; Tae-Wook Chun; Anthony S Fauci
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

7.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

8.  Decreased NK Cell FcRgamma in HIV-1 infected individuals receiving combination antiretroviral therapy: a cross sectional study.

Authors:  Edwin Leeansyah; Jingling Zhou; Geza Paukovics; Sharon R Lewin; Suzanne M Crowe; Anthony Jaworowski
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis.

Authors:  R B Effros; R Allsopp; C P Chiu; M A Hausner; K Hirji; L Wang; C B Harley; B Villeponteau; M D West; J V Giorgi
Journal:  AIDS       Date:  1996-07       Impact factor: 4.177

10.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

View more
  25 in total

Review 1.  Immunometabolism in the development of rheumatoid arthritis.

Authors:  Cornelia M Weyand; Jörg J Goronzy
Journal:  Immunol Rev       Date:  2020-01-27       Impact factor: 12.988

2.  Geriatric-HIV medicine: A science in its infancy.

Authors:  Giovanni Guaraldi; Andrea Cossarizza
Journal:  Virulence       Date:  2017-03-28       Impact factor: 5.882

Review 3.  Immune aging in diabetes and its implications in wound healing.

Authors:  J Moura; P Madureira; E C Leal; A C Fonseca; E Carvalho
Journal:  Clin Immunol       Date:  2019-02-05       Impact factor: 3.969

4.  Implications of Immune Checkpoint Expression During Aging in HIV-Infected People on Antiretroviral Therapy.

Authors:  Lesley R de Armas; Suresh Pallikkuth; Stefano Rinaldi; Rajendra Pahwa; Savita Pahwa
Journal:  AIDS Res Hum Retroviruses       Date:  2019 Nov/Dec       Impact factor: 2.205

5.  Telomere and ATM Dynamics in CD4 T-Cell Depletion in Active and Virus-Suppressed HIV Infections.

Authors:  Sushant Khanal; Qiyuan Tang; Dechao Cao; Juan Zhao; Lam Nhat Nguyen; Oluwayomi Samson Oyedeji; Xindi Dang; Lam Ngoc Thao Nguyen; Madison Schank; Bal Krishna Chand Thakuri; Chinyere Ogbu; Zheng D Morrison; Xiao Y Wu; Zheng Zhang; Qing He; Mohamed El Gazzar; Zhengke Li; Shunbin Ning; Ling Wang; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

6.  Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.

Authors:  Lucette A Cysique; Bruce J Brew
Journal:  J Neurovirol       Date:  2019-01-11       Impact factor: 2.643

7.  Older age at infection and nulliparity are associated with long-term non-progression in female sex workers infected with non-subtype B HIV-1.

Authors:  Vernon Mochache; Barbra A Richardson; Linnet N Masese; Susan M Graham; Kishorchandra Mandaliya; John Kinuthia; Walter Jaoko; Julie Overbaugh; R Scott McClelland
Journal:  Int J STD AIDS       Date:  2020-04-15       Impact factor: 1.359

8.  Phenotypic frailty in people living with HIV is not correlated with age or immunosenescence.

Authors:  Stephen A Klotz; Cesar Egurrola; Maria Love; Mary N Miller; Nicole Bradley; Shannon N Smith; Bijan Najafi; Nafees Ahmad
Journal:  Int J STD AIDS       Date:  2022-04-04       Impact factor: 1.456

Review 9.  Dysfunctional Immunometabolism in HIV Infection: Contributing Factors and Implications for Age-Related Comorbid Diseases.

Authors:  Tiffany R Butterfield; Alan L Landay; Joshua J Anzinger
Journal:  Curr HIV/AIDS Rep       Date:  2020-04       Impact factor: 5.071

10.  Incident Non-AIDS Comorbidity Burden Among Women With or at Risk for Human Immunodeficiency Virus in the United States.

Authors:  Lauren F Collins; Anandi N Sheth; C Christina Mehta; Susanna Naggie; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Seble Kassaye; Tonya N Taylor; Margaret A Fischl; Adaora A Adimora; Mirjam-Colette Kempf; Frank J Palella; Phyllis C Tien; Ighovwerha Ofotokun
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.